机译:miR-34a通过抑制破骨细胞生成和Tgif2来阻止骨质疏松和骨转移
Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
Department of Molecular Biology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
Simmons Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA, Department of Clinical Sciences, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
Division of Cellular and Developmental Biology, Molecular and Cell Biology Department, University of California at Berkeley, Berkeley, California 94705, USA;
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA, Center for RNA Interference and Noncoding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA;
Center for RNA Interference and Noncoding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA;
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA, Center for RNA Interference and Noncoding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA, Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA;
Department of Molecular Biology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA, Simmons Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA, Simmons Cancer Center, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;
机译:收缩注意:MiR-34A通过抑制骨质细胞发生和TGIF2阻断骨质疏松症和骨转移
机译:miR-34a通过抑制*破骨细胞生成和Tgif2来阻止骨质疏松和癌症骨转移
机译:玉兰提取物通过阻断破骨细胞生成并减少破骨细胞介导的骨吸收来抑制卵巢切除术引起的骨质疏松
机译:基于结构的组织蛋白酶L抑制剂和治疗应用癌症转移和癌症诱导的骨质疏松症的治疗方法
机译:SRC-ABL激酶抑制剂,SKI-606,体外和体内阻断乳腺癌侵袭,生长和转移
机译:miR-34a通过抑制破骨细胞生成和Tgif2阻止骨质疏松和骨转移。
机译:收缩注意:MiR-34A通过抑制骨质细胞发生和TGIF2阻断骨质疏松症和骨转移